Myths About Bipolar Affective Disorder: The Role of Structured Group Psychoeducation Therapy

NCT00474357 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2010-12-17

No results posted yet for this study

Summary

This study will examine:

1\) The impact of psycho education group therapy sessions relating to beliefs/myths associated with bipolar affective disorder (BAD) on the emotional wellbeing, clinical course and cognition of individuals diagnosed with BAD 2) Will examine the existence of those same beliefs among the various caregivers - psychiatrists, general practitioners, social workers, and psychiatric nurses.

The investigators hypothesize that psychoeducation group therapy will be effective in refuting the myths and will lead to better treatment adherence, longer remissions, fewer hospitalizations, improved self esteem, increased optimism, and better control over the disease process. The investigators also believe that they will identify some beliefs/myths or preconceived notions that are common to both caregivers and individuals with BAD.

Conditions

  • Bipolar Affective Disorder

Interventions

BEHAVIORAL

Brief Structured Psychoeducation Group Therapy

weekly brief structured psychoeducation group therapy for seven weeks for bipolar patients

Sponsors & Collaborators

  • Lev-Hasharon Mental Healtlh Center

    lead OTHER_GOV

Principal Investigators

  • Igor Oyffe, MD · Lev HaSharon Mental Health Center

  • Deby Peres, MD · Lev HaSharon Mental Health Center

Study Design

Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2008-10-31
Completion
2008-10-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00474357 on ClinicalTrials.gov